CLIMB BIO, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2026-05-04: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2026-04-29; Total offering amount $110,076,289.
- 2024-07-02: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-06-27; Total offering amount $119,999,986.
- 2024-07-02: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-06-27; Total offering amount $41,867,154.
- 2021-05-28: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-05-21; Total offering amount $59,999,987.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2026-05-04 | Rule 506(b) | Equity | 2026-04-29 | $110,076,289 | $110,076,289 | $0 | 22 |
| 2024-07-02 | Rule 506(b) | Equity | 2024-06-27 | $119,999,986 | $119,999,986 | $0 | 8 |
| 2024-07-02 | Rule 506(b) | Equity | 2024-06-27 | $41,867,154 | $41,867,154 | $0 | 6 |
| 2021-05-28 | Rule 506(b) | Equity | 2021-05-21 | $59,999,987 | $59,999,987 | $0 | 9 |
| 2019-10-23 | Rule 506(b) | Equity | 2019-10-10 | $9,999,997 | $9,999,997 | $0 | 1 |
| 2019-10-23 D/A | Rule 506(b) | Equity | 2019-02-04 | $16,302,501 | $16,302,501 | $0 | 6 |
| 2019-02-19 | Rule 506(b) | Equity | 2019-02-04 | $12,240,000 | $12,240,000 | $0 | 4 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |